Life Science Instrumentation Market: Snapshot

In recent few years, there is remarkable growth in research and development activities in field of life science, which is a branch of science that focuses on the study of living organisms and life processes. As a result, there is noteworthy increase in the use of diverse techniques such as chromatography, spectroscopy, next-generation sequencing, polymerase chain reaction, flow cytometry, immunoassays, and clinical chemistry analyzers. This scenario has created promising demand opportunities in the global life science instrumentation market.

With the rising incidence of various infectious diseases such as COVID-19, the government bodies of several countries all across the globe have increased funds toward research activities to find out the medications to control this health condition. This factor is working in favor of the global life science instrumentation market.

Many vendors engaged in the pharmaceutical industry are continuously engaged in evolving new drugs for the treatment of numerous diseases. They are focused on rapid and quick drug development activities. As a result, they are increasing investments in research activities and clinical trials. Thus, these companies are increasing demand for life science instrumentation. This factor is generating promising demand opportunities in the global life science instrumentation market.

The companies engaged in the global life science instrumentation market are growing focus toward introduction of new and technologically advanced products. Apart from this, several enterprises are growing interest in partnerships, collaborations, and joint ventures. This aside, many stakeholders are engaged in mergers and acquisition activities. All these activities are helping enterprises to maintain their leading position in the global life science instrumentation market.

On regional front, North America is one of the dominant regions in the life science instrumentation market. This growth can be attributed to many factors such as sturdy healthcare sector, increased older population, growing number of various lifestyle diseases, and growing research and development activities in pharmaceutical industry of this region.

Life Science Instrumentation Market - Snapshot

The global life science instrumentation market is projected to reach US$ 90 Bn by 2027, expanding at a single digit CAGR during the forecast period. Rise in prevalence and incidence rates of infectious diseases, high R&D investment by major players, and technological advancements are anticipated to drive the global market during the forecast period. According to data published by the Centers for Disease Control and Prevention (CDC), the number of visits to physician offices for infectious and parasitic diseases stood at 16.8 million in the U.S. in 2016. 

life science instrumentation market

The global life science instrumentation market has been segmented based on technique, application, end-user, and region. In terms of technique, the global market has been classified into spectroscopy, chromatography, polymerase chain reaction, next-generation sequencing, clinical chemistry analyzers, flow cytometry, immunoassays, and others. The spectroscopy segment dominated the global market in terms of revenue in 2018. Wide use of spectroscopic techniques in the analysis of molecules in clinical research is anticipated to drive the segment. The next-generation sequencing segment is expected to expand at a high CAGR during the forecast period. Growth of the segment is attributed to increase in R&D initiatives for development of DNA sequencers for genetic applications and new product launches in the smaller DNA sequencers space by major players in the market. 

In terms of application, the global life science instrumentation market has been categorized into research applications, clinical applications, and others. The research applications segment dominated the global market in terms of revenue in 2018. This is attributed to increase in focus of the pharmaceutical industry on quick and rapid drug development and increase in demand for novel drugs for the treatment of rare diseases, which creates a need for high performance analytical instruments and systems. The clinical applications segment is expected to expand at a high CAGR during the forecast period due to increase in use of life science instrumentation in clinical diagnostic applications. According to the International Agency for Research on Cancer (IARC) estimates on the global burden of cancer, there were 18.1 million new cases of cancer and 9.6 million deaths due to the disease in 2018. Moreover, heart and cerebral diseases such as Alzheimer’s disease are posing a significant threat to society. This rise in burden is due to factors such as increase in population and rapid aging and shift from poverty-related diseases to lifestyle diseases in developing countries. These factors drive demand for rapid and non-invasive examination and diagnosis. This in turn is likely to fuel the growth of the clinical applications segment during the forecast period. 

In terms of end-user, the global life science instrumentation market has been divided into research institutes, pharmaceutical & biotechnology companies, diagnostic laboratories, and others. The pharmaceutical & biotechnology companies segment held major share of the market in 2018. The segment is projected to sustain its market share during the forecast period, due to increased use of life science instrumentation in the manufacturing process of drugs in order to maintain the quality of drug throughout the process. The diagnostic laboratories segment is expected to grow at a high CAGR during the forecast period. 

In terms of region, the global life science instrumentation market has been segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America dominated the global market in 2018 owing to increase in geriatric population, rise in prevalence of infectious diseases and lifestyle disorders, rich product pipeline, and technological advancements. The market in Asia Pacific is likely expand at a high CAGR during the forecast period, owing to increase in research initiatives in countries such as India. 

Major players operating in the global life science instrumentation market include Danaher, Thermo Fisher Scientific, Inc., Merck KGaA, Bio-Rad Laboratories, Inc., Agilent Technologies, Inc., Illumina, Inc., PerkinElmer, Inc., BD, Bruker, and Hitachi High-Technologies Corporation. These players are expanding their product portfolios through mergers & acquisitions and partnerships & collaborations with leading pharmaceutical companies, which is expected to increase product availability.

Global Life Science Instrumentation Market: Overview

This report analyzes the current and future scenario of the global life science instrumentation market for the period 2019 to 2027. Rise in prevalence and incidence rates of chronic infectious diseases, increase in investment by key players, and technological advancements are projected to be major drivers of the global life science instrumentation market during the forecast period. 

This report comprises an elaborate executive summary, including a snapshot that provides information on various segments of the global life science instrumentation market. It also provides information and data analysis of the global market with respect to segments based on technique, application, end-user, and region. A detailed qualitative analysis of drivers, restraints, and opportunities of the market has been provided in the overview section. Additionally, the section comprises competitive matrix and profiles of key market players, along with business overview, to project the competitive landscape of the market. The section also provides market attractiveness analysis based on region and market share analysis in terms of key players, thereby presenting a thorough analysis of the overall competitive scenario in the life science instrumentation market. 

Global Life Science Instrumentation Market: Key Segments

Based on technique, the global life science instrumentation market has been segmented into spectroscopy, chromatography, polymerase chain reaction, next-generation sequencing, clinical chemistry analyzers, flow cytometry, immunoassays, and others. In terms of application, the global market has been divided into research applications, clinical applications, and others. Based on end-user, the market has been divided into research institutes, pharmaceutical & biotechnology companies, diagnostic laboratories, and others. The market size and forecast for each of these segments have been provided for the period 2019 to 2027, along with their respective CAGRs for the forecast period from 2019 to 2027, considering 2018 as the base year. 

Global Life Science Instrumentation Market: Regional Outlook

In terms of region, the global life science instrumentation market has been segmented into North America (the U.S. and Canada), Europe (the U.K., Germany, France, Spain, Italy, and Rest of Europe), Asia Pacific (India, China, Japan, Australia & New Zealand, and Rest of Asia Pacific), Latin America (Brazil, Mexico, and Rest of Latin America), and Middle East & Africa (South Africa, GCC Countries, and Rest of Middle East & Africa). Market size and forecast for each of these regions and the mentioned countries have been provided for the period from 2017 to 2027, along with their respective CAGRs for the forecast period from 2019 to 2027, considering 2018 as the base year. The research study also covers the competitive scenario in these regions. 

Companies Mentioned in the Report

The report also profiles major players operating in the global life science instrumentation market based on various attributes such as company overview, financial overview, product portfolio, business strategies, and recent developments. The players covered in the report include Danaher, Thermo Fisher Scientific, Inc., Merck KGaA, Bio-Rad Laboratories, Inc., Agilent Technologies, Inc., Illumina, Inc., PerkinElmer, Inc., BD, Bruker, and Hitachi High-Technologies Corporation. 

This study by TMR is all-encompassing framework of the dynamics of the market. It mainly comprises critical assessment of consumers' or customers' journeys, current and emerging avenues, and strategic framework to enable CXOs take effective decisions.

Our key underpinning is the 4-Quadrant Framework EIRS that offers detailed visualization of four elements:

  • Customer Experience Maps
  • Insights and Tools based on data-driven research
  • Actionable Results to meet all the business priorities
  • Strategic Frameworks to boost the growth journey

The study strives to evaluate the current and future growth prospects, untapped avenues, factors shaping their revenue potential, and demand and consumption patterns in the global market by breaking it into region-wise assessment.

The following regional segments are covered comprehensively:

  • North America
  • Asia Pacific
  • Europe
  • Latin America
  • The Middle East and Africa

The EIRS quadrant framework in the report sums up our wide spectrum of data-driven research and advisory for CXOs to help them make better decisions for their businesses and stay as leaders.

Below is a snapshot of these quadrants.

1. Customer Experience Map

The study offers an in-depth assessment of various customers’ journeys pertinent to the market and its segments. It offers various customer impressions about the products and service use. The analysis takes a closer look at their pain points and fears across various customer touchpoints. The consultation and business intelligence solutions will help interested stakeholders, including CXOs, define customer experience maps tailored to their needs. This will help them aim at boosting customer engagement with their brands.

2. Insights and Tools

The various insights in the study are based on elaborate cycles of primary and secondary research the analysts engage with during the course of research. The analysts and expert advisors at TMR adopt industry-wide, quantitative customer insights tools and market projection methodologies to arrive at results, which makes them reliable. The study not just offers estimations and projections, but also an uncluttered evaluation of these figures on the market dynamics. These insights merge data-driven research framework with qualitative consultations for business owners, CXOs, policy makers, and investors. The insights will also help their customers overcome their fears.

3. Actionable Results

The findings presented in this study by TMR are an indispensable guide for meeting all business priorities, including mission-critical ones. The results when implemented have shown tangible benefits to business stakeholders and industry entities to boost their performance. The results are tailored to fit the individual strategic framework. The study also illustrates some of the recent case studies on solving various problems by companies they faced in their consolidation journey.

4. Strategic Frameworks

The study equips businesses and anyone interested in the market to frame broad strategic frameworks. This has become more important than ever, given the current uncertainty due to COVID-19. The study deliberates on consultations to overcome various such past disruptions and foresees new ones to boost the preparedness. The frameworks help businesses plan their strategic alignments for recovery from such disruptive trends. Further, analysts at TMR helps you break down the complex scenario and bring resiliency in uncertain times.

The report sheds light on various aspects and answers pertinent questions on the market. Some of the important ones are:

1. What can be the best investment choices for venturing into new product and service lines?

2. What value propositions should businesses aim at while making new research and development funding?

3. Which regulations will be most helpful for stakeholders to boost their supply chain network?

4. Which regions might see the demand maturing in certain segments in near future?

5. What are the some of the best cost optimization strategies with vendors that some well-entrenched players have gained success with?

6. Which are the key perspectives that the C-suite are leveraging to move businesses to new growth trajectory?

7. Which government regulations might challenge the status of key regional markets?

8. How will the emerging political and economic scenario affect opportunities in key growth areas?

9. What are some of the value-grab opportunities in various segments?

10. What will be the barrier to entry for new players in the market?

The global life science instrumentation market has been segmented as below: 

Technique

  • Spectroscopy
  • Chromatography
  • Polymerase Chain Reaction
  • Next-generation Sequencing
  • Clinical Chemistry Analyzers
  • Flow Cytometry
  • Immunoassays
  • Others

Application

  • Research Applications
  • Clinical Applications
  • Others

End-user

  • Research Institutes
  • Pharmaceutical & Biotechnology Companies
  • Diagnostic Laboratories
  • Others

Region

  • North America
    • U.S.
    • Canada
  • Europe
    • U.K.
    • Germany
    • France
    • Italy
    • Spain
    • Rest of Europe
  • Asia Pacific
    • India
    • China
    • Japan
    • Australia & New Zealand
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East & Africa
    • South Africa
    • GCC Countries
    • Rest of Middle East & Africa

Note: Although care has been taken to maintain the highest levels of accuracy in TMR’s reports, recent market/vendor-specific changes may take time to reflect in the analysis.

1. Preface
       1.1. Market Definition and Scope
       1.2. Market Segmentation
       1.3. Key Research Objectives
       1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary: Global Life Science Instrumentation Market

4. Market Overview
       4.1. Introduction
                 4.1.1. Product Definition
                 4.1.2. Industry Evolution / Developments
       4.2. Overview
       4.3. Market Dynamics
                 4.3.1. Drivers
                 4.3.2. Restraints
                 4.3.3. Opportunities
       4.4. Global Life Science Instrumentation Market Analysis and Forecast, 2017–2027
                 4.4.1. Market Revenue Projections (US$ Mn)

5. Market Outlook
       5.1. Reimbursement Scenario, by Region/globally
       5.2. Key Mergers & Acquisitions 
       5.3. Technological Advancement

6. Global Life Science Instrumentation Market Analysis and Forecast, by Technique 
       6.1. Introduction & Definition
       6.2. Key Findings / Developments
       6.3. Market Value Forecast, by Technique, 2017–2027
                 6.3.1. Spectroscopy 
                 6.3.2. Chromatography 
                 6.3.3. Polymerase Chain Reaction 
                 6.3.4. Next-generation Sequencing
                 6.3.5. Clinical Chemistry Analyzers
                 6.3.6. Flow Cytometry
                 6.3.7. Immunoassays
                 6.3.8. Others
       6.4. Market Attractiveness, by Technique 

7. Global Life Science Instrumentation Market Analysis and Forecast, by Application 
       7.1. Introduction & Definition
       7.2. Key Findings / Developments
       7.3. Market Value Forecast, by Application, 2017–2027
                 7.3.1. Research Applications
                 7.3.2. Clinical Applications 
                 7.3.3. Others 
       7.4. Market Attractiveness, by Application 

8. Global Life Science Instrumentation Market Analysis and Forecast, by End-user 
       8.1. Introduction & Definition
       8.2. Key Findings / Developments
       8.3. Market Value Forecast, by End-user, 2017–2027
                 8.3.1. Research Institutes 
                 8.3.2. Pharmaceutical & Biotechnology Companies
                 8.3.3. Diagnostic Laboratories 
                 8.3.4. Others
       8.4. Market Attractiveness, by End-user 

9. Global Life Science Instrumentation Market Analysis and Forecast, by Region
       9.1. Key Findings
       9.2. Market Value Forecast, by Region
                 9.2.1. North America
                 9.2.2. Europe 
                 9.2.3. Asia Pacific 
                 9.2.4. Latin America 
                 9.2.5. Middle East & Africa
       9.3. Market Attractiveness, by Country/Region

10. North America Life Science Instrumentation Market Analysis and Forecast
       10.1. Introduction
                 10.1.1. Key Findings
       10.2. Market Value Forecast, by Technique, 2017–2027
                 10.2.1. Spectroscopy 
                 10.2.2. Chromatography 
                 10.2.3. Polymerase Chain Reaction 
                 10.2.4. Next-generation Sequencing
                 10.2.5. Clinical Chemistry Analyzers
                 10.2.6. Flow Cytometry
                 10.2.7. Immunoassays
                 10.2.8. Others
       10.3. Market Value Forecast, by Application, 2017–2027
                 10.3.1. Research Applications
                 10.3.2. Clinical Applications 
                 10.3.3. Others 
       10.4. Market Value Forecast, by End-user, 2017–2027
                 10.4.1. Research Institutes 
                 10.4.2. Pharmaceutical & Biotechnology Companies
                 10.4.3. Diagnostic Laboratories 
                 10.4.4. Others
       10.5. Market Value Forecast, by Country, 2017–2027
                 10.5.1. U.S.
                 10.5.2. Canada
       10.6. Market Attractiveness Analysis 
                 10.6.1. By Technique 
                 10.6.2. By Application 
                 10.6.3. By End-user 
                 10.6.4. By Country

11. Europe Life Science Instrumentation Market Analysis and Forecast
       11.1. Introduction
                 11.1.1. Key Findings
       11.2. Market Value Forecast, by Technique, 2017–2027
                 11.2.1. Spectroscopy 
                 11.2.2. Chromatography 
                 11.2.3. Polymerase Chain Reaction 
                 11.2.4. Next-generation Sequencing
                 11.2.5. Clinical Chemistry Analyzers
                 11.2.6. Flow Cytometry
                 11.2.7. Immunoassays
                 11.2.8. Others
       11.3. Market Value Forecast, by Application, 2017–2027
                 11.3.1. Research Applications
                 11.3.2. Clinical Applications 
                 11.3.3. Others 
       11.4. Market Value Forecast, by End-user, 2017–2027
                 11.4.1. Research Institutes 
                 11.4.2. Pharmaceutical & Biotechnology Companies
                 11.4.3. Diagnostic Laboratories 
                 11.4.4. Others
       11.5. Market Value Forecast, by Country/Sub-region, 2017–2027
                 11.5.1. Germany
                 11.5.2. U.K.
                 11.5.3. France
                 11.5.4. Italy
                 11.5.5. Spain
                 11.5.6. Rest of Europe
       11.6. Market Attractiveness Analysis 
                 11.6.1. By Technique 
                 11.6.2. By Application 
                 11.6.3. By End-user 
                 11.6.4. By Country/Sub-region

12. Asia Pacific Life Science Instrumentation Market Analysis and Forecast
       12.1. Introduction
                 12.1.1. Key Findings
       12.2. Market Value Forecast, by Technique, 2017–2027
                 12.2.2. Chromatography 
                 12.2.3. Polymerase Chain Reaction 
                 12.2.4. Next-generation Sequencing
                 12.2.5. Clinical Chemistry Analyzers
                 12.2.6. Flow Cytometry
                 12.2.7. Immunoassays
                 12.2.8. Others
       12.3. Market Value Forecast, by Application, 2017–2027
                 12.3.1. Research Applications
                 12.3.2. Clinical Applications 
                 12.3.3. Others 
       12.4. Market Value Forecast, by End-user, 2017–2027
                 12.4.1. Research Institutes 
                 12.4.2. Pharmaceutical & Biotechnology Companies
                 12.4.3. Diagnostic Laboratories 
                 12.4.4. Others
       12.5. Market Value Forecast, by Country/Sub-region, 2017–2027
                 12.5.1. China
                 12.5.2. Japan
                 12.5.3. India
                 12.5.4. Australia & New Zealand 
                 12.5.5. Rest of Asia Pacific
       12.6. Market Attractiveness Analysis 
                 12.6.1. By Technique 
                 12.6.2. By Application 
                 12.6.3. By End-user 
                 12.6.4. By Country/Sub-region

13. Latin America Life Science Instrumentation Market Analysis and Forecast
       13.1. Introduction
                 13.1.1. Key Findings
       13.2. Market Value Forecast, by Technique, 2017–2027
                 13.2.1. Spectroscopy 
                 13.2.2. Chromatography 
                 13.2.3. Polymerase Chain Reaction 
                 13.2.4. Next-generation Sequencing
                 13.2.5. Clinical Chemistry Analyzers
                 13.2.6. Flow Cytometry
                 13.2.7. Immunoassays
                 13.2.8. Others
       13.3. Market Value Forecast, by Application, 2017–2027
                 13.3.1. Research Applications
                 13.3.2. Clinical Applications 
                 13.3.3. Others 
       13.4. Market Value Forecast, by End-user, 2017–2027
                 13.4.1. Research Institutes 
                 13.4.2. Pharmaceutical & Biotechnology Companies
                 13.4.3. Diagnostic Laboratories 
                 13.4.4. Others
       13.5. Market Value Forecast, by Country/Sub-region, 2017–2027
                 13.5.1. Brazil
                 13.5.2. Mexico
                 13.5.3. Rest of Latin America
       13.6. Market Attractiveness Analysis 
                 13.6.1. By Technique 
                 13.6.2. By Application 
                 13.6.3. By End-user 
                 13.6.4. By Country/Sub-region

14. Middle East & Africa Life Science Instrumentation Market Analysis and Forecast
       14.1. Introduction
                 14.1.1. Key Findings
       14.2. Market Value Forecast, by Technique, 2017–2027
                 14.2.1. Spectroscopy 
                 14.2.2. Chromatography 
                 14.2.3. Polymerase Chain Reaction 
                 14.2.4. Next-generation Sequencing
                 14.2.5. Clinical Chemistry Analyzers
                 14.2.6. Flow Cytometry
                 14.2.7. Immunoassays
                 14.2.8. Others
       14.3. Market Value Forecast, by Application, 2017–2027
                 14.3.1. Research Applications
                 14.3.2. Clinical Applications 
                 14.3.3. Others 
       14.4. Market Value Forecast, by End-user, 2017–2027
                 14.4.1. Research Institutes 
                 14.4.2. Pharmaceutical & Biotechnology Companies
                 14.4.3. Diagnostic Laboratories 
                 14.4.4. Others
       14.5. Market Value Forecast, by Country/Sub-region, 2017–2027
                 14.5.1. GCC Countries 
                 14.5.2. South Africa
                 14.5.3. Rest of Middle East & Africa
       14.6. Market Attractiveness Analysis 
                 14.6.1. By Technique 
                 14.6.2. By Application 
                 14.6.3. By End-user 
                 14.6.4. By Country/Sub-region

15. Competition Landscape
       15.1. Company Profiles
                 15.1.1. Danaher
                             15.1.1.1. Company Overview (HQ, Business Segments, Employee Strength)
                             15.1.1.2. Product Portfolio
                             15.1.1.3. SWOT Analysis
                             15.1.1.4. Financial Overview
                             15.1.1.5. Strategic Overview
                 15.1.2. Thermo Fisher Scientific, Inc.
                             15.1.2.1. Company Overview (HQ, Business Segments, Employee Strength)
                             15.1.2.2. Product Portfolio
                             15.1.2.3. SWOT Analysis
                             15.1.2.4. Financial Overview
                             15.1.2.5. Strategic Overview
                 15.1.3. Merck KGaA
                             15.1.3.1. Company Overview (HQ, Business Segments, Employee Strength)
                             15.1.3.2. Product Portfolio
                             15.1.3.3. SWOT Analysis
                             15.1.3.4. Financial Overview
                             15.1.3.5. Strategic Overview
                 15.1.4. Bio-Rad Laboratories, Inc.
                             15.1.4.1. Company Overview (HQ, Business Segments, Employee Strength)
                             15.1.4.2. Product Portfolio
                             15.1.4.3. SWOT Analysis
                             15.1.4.4. Financial Overview
                             15.1.4.5. Strategic Overview
                 15.1.5. Agilent Technologies, Inc.
                             15.1.5.1. Company Overview (HQ, Business Segments, Employee Strength)
                             15.1.5.2. Product Portfolio
                             15.1.5.3. SWOT Analysis
                             15.1.5.4. Financial Overview
                             15.1.5.5. Strategic Overview
                 15.1.6. Illumina, Inc.
                             15.1.6.1. Company Overview (HQ, Business Segments, Employee Strength)
                             15.1.6.2. Product Portfolio
                             15.1.6.3. SWOT Analysis
                             15.1.6.4. Financial Overview
                             15.1.6.5. Strategic Overview
                 15.1.7. PerkinElmer, Inc.
                             15.1.7.1. Company Overview (HQ, Business Segments, Employee Strength)
                             15.1.7.2. Product Portfolio
                             15.1.7.3. SWOT Analysis
                             15.1.7.4. Financial Overview
                             15.1.7.5. Strategic Overview
                 15.1.8. BD
                             15.1.8.1. Company Overview (HQ, Business Segments, Employee Strength)
                             15.1.8.2. Product Portfolio
                             15.1.8.3. SWOT Analysis
                             15.1.8.4. Financial Overview
                             15.1.8.5. Strategic Overview
                 15.1.9. Bruker
                             15.1.9.1. Company Overview (HQ, Business Segments, Employee Strength)
                             15.1.9.2. Product Portfolio
                             15.1.9.3. SWOT Analysis
                             15.1.9.4. Financial Overview
                             15.1.9.5. Strategic Overview
                 15.1.10. Hitachi High-Technologies Corporation
                             15.1.10.1. Company Overview (HQ, Business Segments, Employee Strength)
                             15.1.10.2. Product Portfolio
                             15.1.10.3. SWOT Analysis
                             15.1.10.4. Financial Overview
                             15.1.10.5. Strategic Overview

List of Tables
Table 01: Global Life Science Instrumentation Market Size (US$ Mn) Forecast, by Technique, 2017–2027
Table 02: Global Life Science Instrumentation Market Value (US$ Mn) Forecast, by Application, 2017–2027
Table 03: Global Life Science Instrumentation Market Value (US$ Mn) Forecast, by End-user, 2017–2027
Table 04: Global Life Science Instrumentation Market Value (US$ Mn) Forecast, by Region, 2017–2027
Table 05: North America Life Science Instrumentation Market Value (US$ Mn) Forecast, by Country, 2017–2027
Table 06: North America Life Science Instrumentation Market Value (US$ Mn) Forecast, by Technique, 2017–2027
Table 07: North America Life Science Instrumentation Market Value (US$ Mn) Forecast, by Application, 2017–2027
Table 08: North America Life Science Instrumentation Market Value (US$ Mn) Forecast, by End-user, 2017–2027
Table 09: U.S. Life Science Instrumentation Market Value (US$ Mn) Forecast, by Technique, 2017–2027
Table 10: U.S. Life Science Instrumentation Market Value (US$ Mn) Forecast, by Application, 2017–2027
Table 11: U.S. Life Science Instrumentation Market Value (US$ Mn) Forecast, by End-user, 2017–2027
Table 12: Canada Life Science Instrumentation Market Value (US$ Mn) Forecast, by Technique, 2017–2027
Table 13: Canada Life Science Instrumentation Market Value (US$ Mn) Forecast, by Application, 2017–2027
Table 14: Canada Life Science Instrumentation Market Value (US$ Mn) Forecast, by End-user, 2017–2027
Table 15: Europe Life Science Instrumentation Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027
Table 16: Europe Life Science Instrumentation Market Value (US$ Mn) Forecast, by Technique, 2017–2027
Table 17: Europe Life Science Instrumentation Market Value (US$ Mn) Forecast, by Application, 2017–2027
Table 18: Europe Life Science Instrumentation Market Value (US$ Mn) Forecast, by End-user, 2017–2027
Table 19: Germany Life Science Instrumentation Market Value (US$ Mn) Forecast, by Technique, 2017–2027
Table 20: Germany Life Science Instrumentation Market Value (US$ Mn) Forecast, by Application, 2017–2027
Table 21: Germany Life Science Instrumentation Market Value (US$ Mn) Forecast, by End-user, 2017–2027
Table 22: U.K. Life Science Instrumentation Market Value (US$ Mn) Forecast, by Technique, 2017–2027
Table 23: U.K. Life Science Instrumentation Market Value (US$ Mn) Forecast, by Application, 2017–2027
Table 24: U.K. Life Science Instrumentation Market Value (US$ Mn) Forecast, by End-user, 2017–2027
Table 25: France Life Science Instrumentation Market Value (US$ Mn) Forecast, by Technique, 2017–2027
Table 26: France Life Science Instrumentation Market Value (US$ Mn) Forecast, by Application, 2017–2027
Table 27: France Life Science Instrumentation Market Value (US$ Mn) Forecast, by End-user, 2017–2027
Table 28: Italy Life Science Instrumentation Market Value (US$ Mn) Forecast, by Technique, 2017–2027
Table 29: Italy Life Science Instrumentation Market Value (US$ Mn) Forecast, by Application, 2017–2027
Table 30: Italy Life Science Instrumentation Market Value (US$ Mn) Forecast, by End-user, 2017–2027
Table 31: Spain Life Science Instrumentation Market Value (US$ Mn) Forecast, by Technique, 2017–2027
Table 32: Spain Life Science Instrumentation Market Value (US$ Mn) Forecast, by Application, 2017–2027
Table 33: Spain Life Science Instrumentation Market Value (US$ Mn) Forecast, by End-user, 2017–2027
Table 34: Rest of Europe Life Science Instrumentation Market Value (US$ Mn) Forecast, by Technique, 2017–2027
Table 35: Rest of Europe Life Science Instrumentation Market Value (US$ Mn) Forecast, by Application, 2017–2027
Table 36: Rest of Europe Life Science Instrumentation Market Value (US$ Mn) Forecast, by End-user, 2017–2027
Table 37: Asia Pacific Life Science Instrumentation Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027
Table 38: Asia Pacific Life Science Instrumentation Market Value (US$ Mn) Forecast, by Technique, 2017–2027
Table 39: Asia Pacific Life Science Instrumentation Market Value (US$ Mn) Forecast, by Application, 2017–2027
Table 40: Europe Life Science Instrumentation Market Value (US$ Mn) Forecast, by End-user, 2017–2027
Table 41: Japan Life Science Instrumentation Market Value (US$ Mn) Forecast, by Technique, 2017–2027
Table 42: Japan Life Science Instrumentation Market Value (US$ Mn) Forecast, by Application, 2017–2027
Table 43: Japan Life Science Instrumentation Market Value (US$ Mn) Forecast, by End-user, 2017–2027
Table 44: China Life Science Instrumentation Market Value (US$ Mn) Forecast, by Technique, 2017–2027
Table 45: China Life Science Instrumentation Market Value (US$ Mn) Forecast, by Application, 2017–2027
Table 46: China Life Science Instrumentation Market Value (US$ Mn) Forecast, by End-user, 2017–2027
Table 47: India Life Science Instrumentation Market Value (US$ Mn) Forecast, by Technique, 2017–2027
Table 48: India Life Science Instrumentation Market Value (US$ Mn) Forecast, by Application, 2017–2027
Table 49: India Life Science Instrumentation Market Value (US$ Mn) Forecast, by End-user, 2017–2027
Table 50: Australia & New Zealand Life Science Instrumentation Market Value (US$ Mn) Forecast, by Technique, 2017–2027
Table 51: Australia & New Zealand Life Science Instrumentation Market Value (US$ Mn) Forecast, by Application, 2017–2027
Table 52: Australia & New Zealand Life Science Instrumentation Market Value (US$ Mn) Forecast, by End-user, 2017–2027
Table 53: Rest of Asia Pacific Life Science Instrumentation Market Value (US$ Mn) Forecast, by Technique, 2017–2027
Table 54: Rest of Asia Pacific Life Science Instrumentation Market Value (US$ Mn) Forecast, by Application, 2017–2027
Table 55: Rest of Asia Pacific Life Science Instrumentation Market Value (US$ Mn) Forecast, by End-user, 2017–2027
Table 56: Latin America Life Science Instrumentation Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027
Table 57: Latin America Life Science Instrumentation Market Value (US$ Mn) Forecast, by Technique, 2017–2027
Table 58: Latin America Life Science Instrumentation Market Value (US$ Mn) Forecast, by Application, 2017–2027
Table 59: Latin America Life Science Instrumentation Market Value (US$ Mn) Forecast, by End-user, 2017–2027
Table 60: Brazil Life Science Instrumentation Market Value (US$ Mn) Forecast, by Technique, 2017–2027
Table 61: Brazil Life Science Instrumentation Market Value (US$ Mn) Forecast, by Application, 2017–2027
Table 62: Brazil Life Science Instrumentation Market Value (US$ Mn) Forecast, by End-user, 2017–2027
Table 63: Mexico Life Science Instrumentation Market Value (US$ Mn) Forecast, by Technique, 2017–2027
Table 64: Mexico Life Science Instrumentation Market Value (US$ Mn) Forecast, by Application, 2017–2027
Table 65: Mexico Life Science Instrumentation Market Value (US$ Mn) Forecast, by End-user, 2017–2027
Table 66: Rest of Latin America Life Science Instrumentation Market Value (US$ Mn) Forecast, by Technique, 2017–2027
Table 67: Rest of Latin America Life Science Instrumentation Market Value (US$ Mn) Forecast, by Application, 2017–2027
Table 68: Rest of Latin America Life Science Instrumentation Market Value (US$ Mn) Forecast, by End-user, 2017–2027
Table 69: Middle East & Africa Life Science Instrumentation Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027
Table 70: Middle East & Africa Life Science Instrumentation Market Value (US$ Mn) Forecast, by Technique, 2017–2027
Table 71: Middle East & Africa Life Science Instrumentation Market Value (US$ Mn) Forecast, by Application, 2017–2027
Table 72: Middle East & Africa Life Science Instrumentation Market Value (US$ Mn) Forecast, by End-user, 2017–2027
Table 73: GCC Countries Life Science Instrumentation Market Value (US$ Mn) Forecast, by Technique, 2017–2027
Table 74: GCC Countries Life Science Instrumentation Market Value (US$ Mn) Forecast, by Application, 2017–2027
Table 75: GCC Countries Life Science Instrumentation Market Value (US$ Mn) Forecast, by End-user, 2017–2027
Table 76: South Africa Life Science Instrumentation Market Value (US$ Mn) Forecast, by Technique, 2017–2027
Table 77: South Africa Life Science Instrumentation Market Value (US$ Mn) Forecast, by Application, 2017–2027
Table 78: South Africa Life Science Instrumentation Market Value (US$ Mn) Forecast, by End-user, 2017–2027
Table 79: Rest of Middle East & Africa Life Science Instrumentation Market Value (US$ Mn) Forecast, by Technique, 2017–2027
Table 80: Rest of Middle East & Africa Life Science Instrumentation Market Value (US$ Mn) Forecast, by Application, 2017–2027
Table 81: Rest of Middle East & Africa Life Science Instrumentation Market Value (US$ Mn) Forecast, by End-user, 2017–2027

List of Figures
Figure 01: Global Life Science Instrumentation Market Size (US$ Mn) and Distribution, by Region, 2018 and 2027
Figure 02: Market Snapshot of Global Life Science Instrumentation Market 
Figure 03: Market Opportunity Map, Revenue Share, by Technique
Figure 04: Market Opportunity Map, Revenue Share, by Application
Figure 05: Market Opportunity Map, Revenue Share, by End-user
Figure 06: Global Life Science Instrumentation Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017–2027
Figure 07: Global Life Science Instrumentation Market Value Share, by Technique, 2018
Figure 08: Global Life Science Instrumentation Market Value Share, by Application, 2018
Figure 09: Global Life Science Instrumentation Market Value Share, by End-user, 2018
Figure 10: Global Life Science Instrumentation Market Value Share, by Region, 2018
Figure 11: Global Life Science Instrumentation Market Value Share Analysis, by Technique, 2018 and 2027
Figure 12: Global Life Science Instrumentation Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Spectroscopy, 2017–2027
Figure 13: Global Custom Procedure Packs Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Chromatography, 2017–2027
Figure 14: Global Life Science Instrumentation Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Polymerase Chain Reaction, 2017–2027
Figure 15: Global Custom Procedure Packs Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Next-generation Sequencing, 2017–2027
Figure 16: Global Life Science Instrumentation Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Clinical Chemistry Analyzers, 2017–2027
Figure 17: Global Custom Procedure Packs Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Flow Cytometry, 2017–2027
Figure 18: Global Life Science Instrumentation Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Immunoassays, 2017–2027
Figure 19: Global Custom Procedure Packs Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Others, 2017–2027
Figure 20: Global Life Science Instrumentation Market Attractiveness, by Technique, 2019–2027
Figure 21: Global Life Science Instrumentation Market Value Share Analysis, by Application, 2018 and 2027
Figure 22: Global Life Science Instrumentation Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Research Applications, 2017–2027
Figure 23: Global Life Science Instrumentation Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Clinical Applications, 2017–2027
Figure 24: Global Life Science Instrumentation Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Others, 2017–2027
Figure 25: Global Life Science Instrumentation Market Attractiveness Analysis, by Application, 2019–2027
Figure 26: Global Life Science Instrumentation Market Value Share Analysis, by End-user, 2018 and 2027
Figure 27: Global Life Science Instrumentation Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Research Institutes, 2017–2027
Figure 28: Global Life Science Instrumentation Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Pharmaceutical & Biotechnology Companies, 2017–2027
Figure 29: Global Life Science Instrumentation Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Diagnostic Laboratories, 2017–2027
Figure 30: Global Life Science Instrumentation Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Others, 2017–2027
Figure 31: Global Life Science Instrumentation Market Attractiveness Analysis, by End-user, 2019–2027
Figure 32: Global Life Science Instrumentation Market Value Share (%), by Region, 2018 and 2027
Figure 33: Global Life Science Instrumentation Market Attractiveness, by Region, 2019–2027
Figure 34: North America Life Science Instrumentation Market Value (US$ Mn) Forecast and Y-o-Y Growth Projection (%), 2017–2027
Figure 35: North America Life Science Instrumentation Market Value Share, by Country, 2018 and 2027
Figure 36: North America Life Science Instrumentation Market Attractiveness, by Country, 2019–2027
Figure 37: North America Life Science Instrumentation Market Value Share, by Technique, 2018 and 2027
Figure 38: North America Life Science Instrumentation Market Attractiveness, by Technique, 2019–2027
Figure 39: North America Life Science Instrumentation Market Value Share, by Application, 2018 and 2027
Figure 40: North America Life Science Instrumentation Market Attractiveness, by Application, 2019–2027
Figure 41: North America Life Science Instrumentation Market Value Share, by End-user, 2018 and 2027
Figure 42: North America Life Science Instrumentation Market Attractiveness, by End-user, 2019–2027
Figure 43: Europe Life Science Instrumentation Market Value (US$ Mn) Forecast and Y-o-Y Growth Projection (%), 2017–2027
Figure 44: Europe Life Science Instrumentation Market Value Share, by Country/Sub-region, 2018 and 2027
Figure 45: Europe Life Science Instrumentation Market Attractiveness, by Country/Sub-region, 2019–2027
Figure 46: Europe Life Science Instrumentation Market Value Share, by Technique, 2018 and 2027
Figure 47: Europe Life Science Instrumentation Market Attractiveness, by Technique, 2019–2027
Figure 48: Europe Life Science Instrumentation Market Value Share, by Application, 2018 and 2027
Figure 49: Europe Life Science Instrumentation Market Attractiveness, by Application, 2019–2027
Figure 50: Europe Life Science Instrumentation Market Value Share, by End-user, 2018 and 2027
Figure 51: Europe Life Science Instrumentation Market Attractiveness, by End-user, 2019–2027
Figure 52: Asia Pacific Life Science Instrumentation Market Value (US$ Mn) Forecast and Y-o-Y Growth Projection (%), 2017–2027
Figure 53: Asia Pacific Life Science Instrumentation Market Value Share, by Country/Sub-region, 2018 and 2027
Figure 54: Asia Pacific Life Science Instrumentation Market Attractiveness, by Country/Sub-region, 2019–2027
Figure 55: Asia Pacific Life Science Instrumentation Market Value Share, by Technique, 2018 and 2027
Figure 56: Asia Pacific Life Science Instrumentation Market Attractiveness, by Technique, 2019–2027
Figure 57: Asia Pacific Life Science Instrumentation Market Value Share, by Application, 2018 and 2027
Figure 58: Asia Pacific Life Science Instrumentation Market Attractiveness, by Application, 2019–2027
Figure 59: Asia Pacific Life Science Instrumentation Market Value Share, by End-user, 2018 and 2027
Figure 60: Asia Pacific Life Science Instrumentation Market Attractiveness, by End-user, 2019–2027
Figure 61: Latin America Life Science Instrumentation Market Value (US$ Mn) Forecast and Y-o-Y Growth Projection (%), 2017–2027
Figure 62: Latin America Life Science Instrumentation Market Attractiveness, by Country/Sub-region, 2019–2027
Figure 63: Latin America Life Science Instrumentation Market Value Share, by Country/Sub-region, 2018 and 2027
Figure 64: Latin America Life Science Instrumentation Market Value Share, by Technique, 2018 and 2027
Figure 65: Latin America Life Science Instrumentation Market Attractiveness, by Technique, 2019–2027
Figure 66: Latin America Life Science Instrumentation Market Value Share, by Application, 2018 and 2027
Figure 67: Latin America Life Science Instrumentation Market Attractiveness, by Application, 2019–2027
Figure 68: Latin America Life Science Instrumentation Market Value Share, by End-user, 2018 and 2027
Figure 69: Latin America Life Science Instrumentation Market Attractiveness, by End-user, 2019–2027
Figure 70: Middle East & Africa Life Science Instrumentation Market Value (US$ Mn) Forecast and Y-o-Y Growth Projection (%), 2017–2027
Figure 71: Middle East & Africa Life Science Instrumentation Market Attractiveness, by Country/Sub-Region, 2019–2027
Figure 72: Middle East & Africa Life Science Instrumentation Market Value Share, by Country/Sub-Region, 2018 and 2027
Figure 73: Middle East & Africa Life Science Instrumentation Market Value Share, by Technique, 2018 and 2027
Figure 74: Middle East & Africa Life Science Instrumentation Market Attractiveness, by Technique, 2019–2027
Figure 75: Middle East & Africa Life Science Instrumentation Market Value Share, by Application, 2018 and 2027
Figure 76: Middle East & Africa Life Science Instrumentation Market Attractiveness, by Application, 2019–2027
Figure 77: Middle East & Africa Life Science Instrumentation Market Value Share, by End-user, 2018 and 2027
Figure 78: Middle East & Africa Life Science Instrumentation Market Attractiveness, by End-user, 2019–2027

Custom Market Research Services

TMR offers custom market research services that help clients to get information on their business scenario required where syndicated solutions are not enough.

Request Customization

Life Science Instrumentation Market